Pharmacological Therapy for Idiopathic Pulmonary Fibrosis

This publication has 47 references indexed in Scilit:

• Lung Fibrosis is Ameliorated by Pirfenidone Fed in Diet After the Second Dose In A Three-Dose Bleomycin-Hamster Model
  Experimental Lung Research, 1998
• British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society
  Thorax, 1997
• Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats
  Critical Care Medicine, 1996
• Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis.
  Journal of Clinical Investigation, 1996
• New strategies for treatment of pulmonary fibrosis.
  Thorax, 1995
• Human Relaxin Decreases Collagen Accumulation In Vivo in Two Rodent Models of Fibrosis
  Journal of Investigative Dermatology, 1993
• Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.
  Journal of Clinical Investigation, 1993
• Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
  Thorax, 1989
• Survival of medically treated patients in the coronary artery surgery study (CASS) registry.
  Circulation, 1982
• Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
  Thorax, 1980